1Ziyadeh FN,Han DC.Involvement of transforming growth factor-β1 and receptors in the pathogmesis of diabetic nephropathy[J].Kidney Int,1997,52(suppl60):67-69.
1Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstriction peptide produced by vascular endothelia cells. Nature. 1988, 332(6163) :411.
2Ziyadeh FN, Hart DC. Involvement of transforming growth factor - β and its receptors in the pathogenesis of diabetic nephropathy. Kidney Int. 1997,52(suppl60) :67.
3Kohan DE. Endothelins in the kidney: physiology and pathophysiology. Am J Kidney Dis. 1993,22(4) :493.
4Yokoyama H, Dockert T. Central role of TGF - beta in the pathogenesis of diabetic nephropathy and macrovascular complications : a hypothesis. Diabet Med. 1996, 13(4) :313.
5Park IS, Kiyomoto H, Abboud SL, et al. Expression of transforming growth factor - β and type Ⅳ collagen in early streptozotocin - induced diabetes. Diabetes. 1997, 46(3) :473.
6Simon M, Grone HJ, Johren O, et al. Expression of vascular endothelial growth factor and its receptors in human renal oncogenesis and in adult kidney. Am J Physiol. 1995,268(1) :7240.
7Sommer M, Eismann U, Deuther - Conrad W, et al. Time course of cytokine mRNA expression in kidneys of rats with unilateral ureteral obstruction. Nephron, 2000,84 ( 1 ): 49 - 57.
8Kaneto H, Ohtani H, Fukuzaki A, et al. Increased expression of TGF - β1 but not of its receptors contributes to human obstructive nephropathy. Kidney Int, 1999,56(6) :2137 - 46.
9Furness PD, Maizels M, Han SW, et al. J Elevated bladder urine concentration of transforming growth factor - β1 correlates with upper urinary tract obstruction in children. Urol, 1999,162:1033 - 1036.
10MacRae Dell K, Hoffman BB, Leonard MB, et al. Increased urinary transforming growth factor - β( 1 ) excretion in children with posterior urethral valves. Urology,2000,56(2) :311 - 4.
